Literature DB >> 10997831

HCV status knowledge and risk behaviours amongst intravenous drug users.

G Vidal-Trécan1, J Coste, I Varescon-Pousson, B Christoforov, A Boissonnas.   

Abstract

The aim of this study was to identify relationships between injecting and sexual risk behaviours and hepatitis C virus (HCV) status knowledge in intravenous drug users (IDUs). It was a cross-sectional survey (March 1994-June 1995) in 10 drug abuse treatment or psychosocial centres in Paris, France. We used a structured questionnaire about sexual, injecting, HIV and HCV antibody testing practices and results during the previous 6 months. Six hundred and twelve sexually active IDUs aged 18 or older who were current injecting drug users were interviewed. Of 592 respondent IDUs, 37% did not report consistent HCV testing and 34% reported being HCV-positive. HCV-positive IDUs were older than HCV-negatives and HCV-unknowns. HCV-unknowns and HCV-positives had a lower educational level than HCV-negatives. After adjusting for demographic characteristics and HIV status, the factors associated with being HCV-unknown were not using condoms (OR: 2.9; 95% CI: 1.9-4.6) as well as clean equipment (OR: 1.8; 95% CI: 1.2-3.0). Not using new equipment was negatively associated with being HCV-unknown (OR: 0.4; 95% CI: 0.2-0.6) and with being HCV-positive (OR: 0.5; 95% CI: 0.3-0.8). Our study suggests that particular sexual and injecting risk-behaviours are associated with not knowing HCV status. As HCV-unknown IDUs are likely to be at the risk of transmitting HCV or acquiring other infections. HCV testing should be encouraged and associated with sexual counselling. Special attention should be paid to disinfecting practices for HCV-positives and use of new injecting equipment should be recommended for HCV-negatives.

Entities:  

Mesh:

Year:  2000        PMID: 10997831     DOI: 10.1023/a:1007622831518

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  49 in total

1.  Hepatitis C virus infection in homosexual men: a seroepidemiological study in gay clubs in north-east Italy.

Authors:  V Gasparini; M Chiaramonte; M E Moschen; P Fabris; G Altinier; S Majori; C Campello; R Trivello
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.

Authors:  R Corona; G Prignano; A Mele; G Gentili; F Caprilli; E Franco; L Ferrigno; A Giglio; F Titti; C Bruno
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

Review 3.  Methods of transmission of hepatitis C.

Authors:  C J Tibbs
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

4.  Continued risk behaviour among HIV positive drug injectors in London: implications for intervention.

Authors:  T J Rhodes; M C Donoghoe; G M Hunter; G V Stimson
Journal:  Addiction       Date:  1993-11       Impact factor: 6.526

5.  Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.

Authors:  R Wyld; J R Robertson; R P Brettle; J Mellor; L Prescott; P Simmonds
Journal:  J Infect       Date:  1997-09       Impact factor: 6.072

Review 6.  Evidence for the effects of HIV antibody counseling and testing on risk behaviors.

Authors:  D L Higgins; C Galavotti; K R O'Reilly; D J Schnell; M Moore; D L Rugg; R Johnson
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

7.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

8.  Determinants of condom use among intravenous drug users.

Authors:  K E Watkins; D Metzger; G Woody; A T McLellan
Journal:  AIDS       Date:  1993-05       Impact factor: 4.177

9.  Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects.

Authors:  B Galeazzi; A Tufano; E Barbierato; F Bortolotti
Journal:  Liver       Date:  1995-08

10.  Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading?

Authors:  P Alcabes; D Vlahov; J C Anthony
Journal:  Br J Addict       Date:  1992-01
View more
  12 in total

1.  Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.

Authors:  Joseph Cox; Carole Morissette; Prithwish De; Claude Tremblay; Robert Allard; Lisa Graves; Randolph Stephenson; Elise Roy
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

2.  Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.

Authors:  Patrick Habecker; Roberto Abadie; Melissa Welch-Lazoritz; Juan Carlos Reyes; Bilal Khan; Kirk Dombrowski
Journal:  Subst Use Misuse       Date:  2017-11-22       Impact factor: 2.164

3.  Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.

Authors:  V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin
Journal:  Scand J Infect Dis       Date:  2010-09-15

4.  Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.

Authors:  Kate Shannon; Vicki Bright; Janice Duddy; Mark W Tyndall
Journal:  J Urban Health       Date:  2005-06-08       Impact factor: 3.671

5.  High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia.

Authors:  Javier A Cepeda; Linda M Niccolai; Alexandra Lyubimova; Trace Kershaw; Olga Levina; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

6.  Substance use and hepatitis C: an ecological momentary assessment study.

Authors:  Karran A Phillips; David H Epstein; Massoud Vahabzadeh; Mustapha Mezghanni; Jia-Ling Lin; Kenzie L Preston
Journal:  Health Psychol       Date:  2014-07       Impact factor: 4.267

7.  Hepatitis C testing and status among opioid substitution treatment clients in New South Wales.

Authors:  Fiona L Shand; Carolyn Day; William Rawlinson; Louisa Degenhardt; Nicholas G Martin; Elliot C Nelson
Journal:  Aust N Z J Public Health       Date:  2014-04       Impact factor: 2.939

8.  Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.

Authors:  Jessica Willner-Reid; Katherine A Belendiuk; David H Epstein; John Schmittner; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2007-10-10

9.  Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, China.

Authors:  Wei Xiaoli; Wang Lirong; Wang Xueliang; Li Jinsong; Li Hengxin; Jia Wei
Journal:  Hepat Mon       Date:  2014-11-23       Impact factor: 0.660

10.  Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study.

Authors:  Wen Chen; Yinghua Xia; Yan Hong; Brian J Hall; Li Ling
Journal:  Harm Reduct J       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.